FDA Approves Momenta/Sandoz' Lovenox Generic Without Need For Clinical Studies

Agency's five criteria for determining "sameness" of generic enoxaparin to Sanofi-Aventis's low molecular weight heparin could serve as guideposts for future biosimilar approvals.